Sisätautien klinikka

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Airaksinen J. Vaikuttaako potilaan sukupuoli sepelvaltimotaudin hoitoon?
2 Anglé S et al. Weight gain since infancy and prepubertal body dissatisfaction.
3 Collan Y et al. Value of electron microscopy in kidney biopsy diagnosis.
4 Dahlof B et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm. (ASCOT-BPLA): A multicentre randomised controlled trial.
5 de Voogt WG et al. A technique of lead insertion for low atrial septal pacing.
6 Demers C et al. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
7 Elovainio M et al. Depressive symptoms and carotid artery intima-media thickness in young adults: The Cardiovascular Risk in Young Finns Study.
8 Elovainio M et al. Does the level of LDL cholesterol moderate a relationship between DRD4 and novelty seeking?
9 Elovainio M et al. Relationship between DRD4 polymorphism and lipid metabolism: What is the role of novelty seeking?
10 Eriksson S et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies.
11 Eskola MJ et al. Comparative accuracy of manual versus computerized electrocardiographic measurement of J-, ST- ja T-wave deviations in patients with acute coronary syndrome.
12 Fiessinger JN et al. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis.
13 Fossum E et al. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension takin aspirin.
14 Fyhrquist F et al. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
15 Granger BB et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: doubleblind, randomised, controlled clinical trial.
16 Grenman S et al. Vaihdevuosien hormonihoito.
17 Grönroos J et al. Roles of group IIA phospholipase A2 and complement in killing of bacteria by acute phase serum.
18 Hakanen AJ et al. New quinolone resistance phenomenon in salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
19 Halme L et al. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care.
20 Heiro M et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis.
21 Hintsanen M et al. Job strain and early atherosclerosis: The cardiovascular risk in yong finns study.
22 Hohenthal U et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy - value of new microbiological methods.
23 Hämäläinen H et al. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabets Prevention Study.
24 Ilva T et al. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept.
25 Immonen-Räihä P et al. Mammographic screening reduces risk of breast carcinoma recurrence.
26 Impivaara O et al. Osteoporoosin diagnostiikassa kaikki hyvin? Tuloksia eri DXA-laitteilla tehtyjen mittausten vertailusta.
27 Islam Md.S et al. Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finns Study.
28 Jonsson B et al. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
29 Jula A et al. Effects of diet and simvastatin on fatty acid composition in hypercholesterolemic men. A randomized controlled trial.
30 Julkunen L et al. Recovery of somatosensory deficits in acute stroke.
31 Juonala M. Cardiovascular Risk Factors and Their Associations with Markers of Subclinical Atherosclerosis in Young Adults. The Cardiovascular Risk in Young Finns Study.
32 Juonala M et al. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood. The cardiovascular risk in young Finns study.
33 Juonala M et al. Geographic origin as a determinant of carotid artery intima-media thickness and brachial artery flow-mediated dilation. The cardiovascular risk in young Finns study.
34 Juonala M et al. Sepelvaltimotaudin riskitekijät merkityksellisiä lapsuusiästä lähtien. Primaaripreventiota kohdistettava entistä nuorempiin?
35 Juutilainen A et al. Type 2 diabetes as a "coronary heart disease equivalent". An 18-year prospective population-based study in Finnish subjects.
36 Kaarela K et al. How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.
37 Kaarisalo MM et al. Diabetes worsens the outcome of acute ischemic stroke.
38 Kaitosaari T et al. Varhaisen ravitsemusneuvonnan vaikutus lasten seerumin rasva-arvoihin ja kasvuun STRIP-pjojektissa.
39 Kalliokoski RJ et al. Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.
40 Kalliokoski T et al. An autoradiographic study of (18F]FDG uptake to islets of Langerhans in NOD mouse.
41 Kantola I. Pitäisikö kohonneen verenpaineen hoitoa uudistaa?
42 Kantola I. Kohonneen verenpaineen lääkehoito.
43 Kantola I. Hypertension akuutti hoito.
44 Kantola I et al. Bell or diaphragm in the measurement of blood pressure?
45 Karjalainen A et al. Milloin valitaan biologinen hoito reumasairauteen?
46 Karlsson HKR et al. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.
47 Kauppinen-Mäkelin R et al. A Nationwide survey of mortality in acromegaly.
48 Kauppinen-Mäkelin R et al. A nationwide survey of mortality in agromegaly.
49 Kemppainen J et al. High intensity exercise decreases global brain glucose uptake in humans.
50 Ketonen M et al. Keski-ikäisen naisen tahaton laihtuminen.
51 Kilhovd BK et al. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men. A Population-based 18-year follow-up study.
52 Kivimäki M et al. Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults. The cardiovascular risk in young Finns study.
53 Kiviranta R et al. Heikentynyt glukoositasapaino ja puutuvat kädet.
54 Kjeldsen SE et al. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
55 Koistinen J, Raatikainen P. Milloin rytmihäiriöpotilas lähetetään kardiologin konsultaatioon?
56 Koivikko ML et al. Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type 1 diabetes.
57 Kotilainen P et al. Riedel's thyroiditis in a patient with multiple sclerosis.
58 Kotilainen P et al. Infektioepidemioiden selvittely ja hallinta.
59 Kotilainen P et al. Verisuonikatetreihin liittyvät infektiot.
60 Kotilainen P et al. In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.
61 Kuittinen T et al. Outcome of progressive disease after autologous stem cell trasplantation in patients with non-Hodgkin's lymphoma: a nation-wide survey.
62 Kupila L. Aetiological Diagnosis of Acute Central Nervous System Infections in Adults. The Role of PCR.
63 Kupila L et al. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens.
64 Kuuliala A et al. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
65 Kytö V et al. Diagnosis and presentation of fatal myocarditis.
66 Kytö V et al. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.
67 Laaksonen S et al. Thalidomide therapy and polyneuropathy in myeloma patients.
68 Lautamäki R et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study.
69 Lehto M et al. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
70 Lehtopolku M et al. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance.
71 Leino R. Yersiniosis.
72 Leino R. Involuntary weight loss.
73 Lindgren P et al. Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm (ASCOT-LLA).
74 Ling MC et al. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease.
75 Luukinen H, Airaksinen KEJ. Orthostatic hypotension predicts vascular death in older diabetic patients.
76 Malmberg K et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
77 Marniemi J et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects.
78 Mikkilä V et al. Consistent dietary patterns identified from childhood to adulthood: The cardiovascular risk in young Finns study.
79 Möttönen T. Edistysaskelia reumatologiassa.
80 Möttönen T et al., ed. Nivelreuma - tunnista tauti ajoissa, hoida tehokkaasti.
81 Naum A et al. Motion detection and correction for dynamic 15O-water myocardial perfusion PET studies.
82 Nikoskelainen J, Rintala E. Terveiden ja immuunipuutteisten aikuisten rokotukset.
83 Nikoskelainen Jukka, Salonen Juha. Immuunipuutteisten potilaiden infektioiden torjunta .
84 Nowak B et al. Validation of dual-chamber pacemaker diagnostic data using dual-channel stored electrograms.
85 Pajunen P et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease.
86 Poulter NR et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
87 Puolakka K et al. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study.
88 Puolakka K et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis. Five-year experience from the FIN-RACo trial.
89 Putkonen M et al. Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patients.
90 Qin Q-P et al. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy.
91 Raitakari M et al. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults. The Cardiovascular Risk in Young Finns Study.
92 Raitakari OT et al. Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study.
93 Raitakari OT et al. Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy. The special Turku coronary risk factor intervention project for children (STRIP).
94 Rautiainen H et al. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial.
95 Remes K et al. Allogeenisten kantasolusiirtojen kehityssuunnat ja niiden heijastuminen Turun siirtokeskuksen toimintaan ja tuloksiin.
96 Rönnemaa T. Kolmen kuukauden reaaliaikainen glukoosinseuranta parantaa glukoositasapainoa.
97 Rönnemaa T. Mitokondriot ja diabetes.
98 Salomaa V et al. A new definition for myocardial infarction: what difference does it make?
99 Saraste A et al. Kirurgi paransi malabsorption.
100 Saraste M et al. Transthoracic doppler echocardiography as a noninvasive tool to assess coronary artery stenoses-A comparison wiht quantitative coronary angiography.
101 Sever PS et al. Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).
102 Sokka T et al. Conventional disease-modifying antirheumatic drugs in early arthritis.
103 Solomon SD et al. Influence of ejection fraction on cardiovascular outcomes in a board spectrum of heart failure patients.
104 Sundell J et al. Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in type 1 diabetic subjects.
105 Sundell J. Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspects to the initial vascular mechanisms.
106 Sundell J et al. Increased lipoprotein(a) is associated with reduced myocardial vasoreactivity in young healthy men.
107 Sundell J et al. Hyperkalemian aiheuttama bradykardia.
108 Takala T et al. Terbinafiinin aiheuttama vakava maksareaktio ja sen hoito MARS-albumiinidialyysilla.
109 Telama R et al. Physical activity from childhood to adulthood. A 21-year tracking study.
110 Van Gaal LF et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe stydy .
111 Vasankari T et al. Effects of statin therapy on circulating conjugated dienes, a measure of LDL oxidation.
112 Vehmas T et al. Liver echogenicity: relation to systemic blood pressure and other components of the metabolic syndrome.
113 Venojärvi M et al. Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention.
114 Verkasalo MA et al. Undiagnosed silent coeliac disease: A risk for underachievement?
115 Vesalainen R. Koksibit ja sydän- ja verisuonitautien riski.
116 Vesalainen R, Porela P. Miten vähennän säteilyannoksia invasiivisessa kardiologiassa?
117 Viikari J. HDL sepelvaltimotaudin vaaran arvioinnissa.
118 Vikman S et al. Sepelvaltimotautikohtauksen hoito Suomessa.
119 Vikman S et al. Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation.
120 Viljanen APM et al. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: A double-blind, randomized study with metformin.
121 Virtanen KA et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes. A positron-emitting tomography study.
122 Vuopio-Varkila J, Kotilainen P. Methicillin-resistant Staphylococcus aureus (MRSA).
123 Vänttinen M et al. Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.
124 Vänttinen M et al. The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma 2 gene on skeletal muscle glucose uptake depends on obesity - a positron emission tomography study.
125 Wyatt JW et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.
Julkaisutietokanta 4.10.2006 Publications Data Base 4.10.2006